Marc Schneider

825 total citations
35 papers, 582 citations indexed

About

Marc Schneider is a scholar working on Pharmacology, Epidemiology and Molecular Medicine. According to data from OpenAlex, Marc Schneider has authored 35 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pharmacology, 10 papers in Epidemiology and 9 papers in Molecular Medicine. Recurrent topics in Marc Schneider's work include Antibiotics Pharmacokinetics and Efficacy (21 papers), Antibiotic Resistance in Bacteria (9 papers) and Pneumonia and Respiratory Infections (6 papers). Marc Schneider is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (21 papers), Antibiotic Resistance in Bacteria (9 papers) and Pneumonia and Respiratory Infections (6 papers). Marc Schneider collaborates with scholars based in France, Germany and United States. Marc Schneider's co-authors include Bernard Boisramé, Frédérique Woehrlé, V Thomas, Pierre‐Louis Toutain, Alain Bousquet‐mélou, Maria Del Valle, Stephen A. Bernard, Didier Concordet, Farid El Garch and Marcel Feig and has published in prestigious journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and Journal of Dairy Science.

In The Last Decade

Marc Schneider

34 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Schneider France 15 357 186 136 117 112 35 582
Emilio Fernández-Varón Spain 16 396 1.1× 203 1.1× 76 0.6× 115 1.0× 84 0.8× 49 570
Carlos M. Cárceles Spain 17 458 1.3× 218 1.2× 71 0.5× 129 1.1× 95 0.8× 50 641
H. Drugeon France 10 208 0.6× 147 0.8× 136 1.0× 109 0.9× 39 0.3× 37 481
E Huczko United States 15 345 1.0× 273 1.5× 356 2.6× 86 0.7× 47 0.4× 20 806
Pamela McGhee United States 14 286 0.8× 248 1.3× 222 1.6× 131 1.1× 74 0.7× 26 760
Bonifacio Dewasse United States 14 273 0.8× 264 1.4× 367 2.7× 57 0.5× 115 1.0× 21 678
Kim Credito United States 16 308 0.9× 255 1.4× 318 2.3× 165 1.4× 55 0.5× 27 776
J. Prieto Spain 18 397 1.1× 300 1.6× 483 3.6× 122 1.0× 89 0.8× 79 1.0k
Meridith E. Erwin United States 15 370 1.0× 398 2.1× 293 2.2× 293 2.5× 68 0.6× 44 887
Helen T. Fernandez United States 19 170 0.5× 141 0.8× 242 1.8× 299 2.6× 105 0.9× 26 865

Countries citing papers authored by Marc Schneider

Since Specialization
Citations

This map shows the geographic impact of Marc Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Schneider more than expected).

Fields of papers citing papers by Marc Schneider

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Schneider. The network helps show where Marc Schneider may publish in the future.

Co-authorship network of co-authors of Marc Schneider

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Schneider. A scholar is included among the top collaborators of Marc Schneider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Schneider. Marc Schneider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Germann, Anja, et al.. (2025). Development of an inhalable dry powder formulation for inhibition of SARS-CoV-2. International Journal of Pharmaceutics X. 10. 100346–100346. 1 indexed citations
2.
3.
Paepe, Dominique, Mathias Devreese, Bart J. G. Broeckx, et al.. (2022). Pharmacokinetic and pharmacodynamic properties of orally administered torasemide in healthy cats. Journal of Veterinary Internal Medicine. 36(5). 1782–1791. 3 indexed citations
4.
Bousquet‐mélou, Alain, Marc Schneider, Farid El Garch, et al.. (2020). Determination of the pharmacokinetic‐pharmacodynamic cut‐off values of marbofloxacin in horses to support the establishment of a clinical breakpoint for antimicrobial susceptibility testing. Equine Veterinary Journal. 53(5). 1047–1055. 6 indexed citations
5.
Boots, Agnes W., Carmen Veith, Michael Kreuter, et al.. (2020). Towards personalized medicine in idiopathic pulmonary fibrosis by screening exhaled volatiles in patients’ primary bronchial epithelial cells. 605–605. 1 indexed citations
6.
Koppe, Uwe, Lars Eric Kroll, Ines Noll, et al.. (2018). Carbapenem non-susceptibility of Klebsiella pneumoniae isolates in hospitals from 2011 to 2016, data from the German Antimicrobial Resistance Surveillance (ARS). Antimicrobial Resistance and Infection Control. 7(1). 71–71. 32 indexed citations
7.
Lhermie, Guillaume, Aude Ferran, Sébastien Assié, et al.. (2016). Impact of Timing and Dosage of a Fluoroquinolone Treatment on the Microbiological, Pathological, and Clinical Outcomes of Calves Challenged with Mannheimia haemolytica. Frontiers in Microbiology. 7. 237–237. 30 indexed citations
8.
Schneider, Marc, et al.. (2015). Disposition of cimicoxib in plasma and milk of whelping bitches and in their puppies. BMC Veterinary Research. 11(1). 178–178. 6 indexed citations
9.
10.
Schneider, Marc, et al.. (2013). Pharmacokinetic/pharmacodynamic modeling for the determination of a cimicoxib dosing regimen in the dog. BMC Veterinary Research. 9(1). 250–250. 16 indexed citations
11.
Ferran, Aude, Delphine Bibbal, Michel Laurentie, et al.. (2013). Pharmacokinetic/pharmacodynamic assessment of the effects of parenteral administration of a fluoroquinolone on the intestinal microbiota: Comparison of bactericidal activity at the gut versus the systemic level in a pig model. International Journal of Antimicrobial Agents. 42(5). 429–435. 25 indexed citations
12.
Valle, Maria Del, et al.. (2011). Pharmacokinetic and pharmacodynamic testing of marbofloxacin administered as a single injection for the treatment of bovine respiratory disease. Journal of Veterinary Pharmacology and Therapeutics. 35(6). 519–528. 25 indexed citations
13.
Kietzmann, Manfred, et al.. (2007). Tissue distribution of marbofloxacin after ‘systemic’ administration into the isolated perfused bovine udder. The Veterinary Journal. 178(1). 115–118. 12 indexed citations
14.
Schneider, Marc, Maria Del Valle, Frédérique Woehrlé, & Bernard Boisramé. (2004). Pharmacokinetics of Marbofloxacin in Lactating Cows After Repeated Intramuscular Administrations and Pharmacodynamics Against Mastitis Isolated Strains. Journal of Dairy Science. 87(1). 202–211. 51 indexed citations
15.
Peyrou, Mathieu, Michèle Doucet, André Vrins, et al.. (2004). Population pharmacokinetics of marbofloxacin in horses: preliminary analysis. Journal of Veterinary Pharmacology and Therapeutics. 27(5). 283–288. 18 indexed citations
16.
Bousquet‐mélou, Alain, Stephen A. Bernard, Marc Schneider, & Pierre‐Louis Toutain. (2002). Pharmacokinetics of marbofloxacin in horses. Equine Veterinary Journal. 34(4). 366–372. 48 indexed citations
17.
Trautmann, Matthias, Markus Heinemann, M. Seidelmann, et al.. (1999). Endotoxin Release Due to Ciprofloxacin Measured by Three Different Methods. Journal of Chemotherapy. 11(4). 248–254. 11 indexed citations
18.
Dupouy, Véronique, et al.. (1998). Pharmacokinetics of Marbofloxacin in Renal Impairment in the Dog. Veterinary Quarterly. 20(sup1). S104–S104. 3 indexed citations
19.
Jeurissen, Frank J., et al.. (1998). Is the combination of hepatitis and indinavir potentially dangerous?. PubMed. 12(4). 441–2. 11 indexed citations
20.
Schneider, Marc, et al.. (1996). Pharmacokinetics of marbofloxacin in dogs after oral and parenteral administration. Journal of Veterinary Pharmacology and Therapeutics. 19(1). 56–61. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emilio Fernández-Varón Breakdown of academic impact, for papers by Carlos M. Cárceles Breakdown of academic impact, for papers by H. Drugeon Breakdown of academic impact, for papers by E Huczko Breakdown of academic impact, for papers by Pamela McGhee Breakdown of academic impact, for papers by Bonifacio Dewasse Breakdown of academic impact, for papers by Kim Credito Breakdown of academic impact, for papers by J. Prieto Breakdown of academic impact, for papers by Meridith E. Erwin Breakdown of academic impact, for papers by Helen T. Fernandez
Rankless by CCL
2026